Institutional Review Board And how it affects you.
What’s New in the FDA’s Pharmaceutical Inspectorate and Risk Based Systems Inspection Rick Perlman Chair Food, Drug, and Cosmetic Division ASQ.
ARRA FUNDING UPDATE Unprecedented Number of Proposals JIT Requests Extraordinary Reporting Requirements Unique Administrative Characteristics OMB Implementing.
OSP Roundtable January 16, 2013
